>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
肾脏去神经技术:历史,现状和前景
作者:BAO Ruo-tai  陈忠  马根山 
单位:Department of Cardiology, Zhongda Hospital, Southeast University, Najing 210009, China
关键词: 
分类号:R544.1;R454
出版年·卷·期(页码):2014·33·第三期(349-354)
摘要:

Renal denervation is a new technique approved effective for resistant-hypertension treatment. The common renal denervation system consists of a generator and a flexible catheter. During this minimally invasive procedure, the interventionalist uses a steerable catheter with a radio frequency(RF) energy electrode tip. The RF energy is delivered to the renal artery via standard femoral artery access. A series of 2-minute ablation are delivered in each renal artery to distroy the nerves system. The procedure does not involve a permanent device implant. By deactivating the renal nerves, and therefore reducing sympathetic nerve transmission, a significant and reliable reduction in blood pressure could be achieved. In this review, potential complications and future sights of renal denervation are also discussed.

参考文献:

[1] KEARNEY P M,WHELTON M,REYNOLDS K,et al.Global burden of hypertension:analysis of worldwide data[J].Lancet,2005,365(9455):217-223.
[2] EGAN B M,ZHAO Y,AXON R N.US trends in prevalence,awareness,treatment,and control of hypertension,1988-2008[J].JAMA,2010,303:2043-2050.
[3] PEREIRA M,LUNET N,AZEVEDO A,et al.Differences in prevalence,awareness,treatment and control of hypertension between developing and developed countries[J].J Hypertens,2009,27:963-975.
[4] EGAN B M,ZHAO Y,AXON R N,et al.Uncontrolled and apparent treatment resistant hypertension in the United States,1988 to 2008[J].Circulation,2011,124:1046-1058.
[5] LEWINGTON S,CLARKE R,QIZILBASH N,et al.Prospective studies collaboration.Age-specific relevance of usual blood pressure to vascular mortality:a meta-analysis of individual data for one million adults in 61 prospective studies[J].Lancet, 2002,360:1903-1913.
[6] GRASSI G.Assessment of sympathetic cardiovascular drive in human hypertension:achievements and perspectives[J].Hypertension,2009,54:690-697.
[7] SMITHWICK R H,THOMPSON J E.Splanchnicectomy for essential hypertension; results in 1,266 cases[J].J Am Med Assoc,1953,152:1501-1504.
[8] SCHLAICH M P,SOBOTKA P A,KRUM H,et al.Renal denervation as a therapeutic approach for hypertension:novel implications for an old concept[J].Hypertension,2009,54:1195-1201.
[9] ANDERSON E A,SINKEY C A,LAWTON W J,et al.Elevated sympathetic nerve activity in borderline hypertensive humans.Evidence from direct intraneural recordings[J].Hypertension,1989,14:177-183.
[10] SIDDIQI L,JOLES J A,GRASSI G,et al.Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system?[J].J Hypertens,2009,27:1341-1349.
[11] BARAJAS L,LIU L,POWERS K.Anatomy of the renal innervation:intrarenal aspects and ganglia of origin[J].Can J Physiol Pharmacol,1992,70:735-749.
[12] DIBONA G F.Neural control of the kidney:past,present,andfuture[J].Hypertension,2003,41(3 Pt 2):621-624.
[13] DiBONA G F,KOPP U C.Neural control of renal function[J].Physiol Rev,1997,77:75-197.
[14] KOPP U,AURELL M,SJOLANDER M,et al.The role of prostaglandins in the alpha- and beta-adrenoceptor mediated renin release response to graded renal nerve stimulation[J].Pflugers Arch,1981,391:1-8.
[15] STELLA A,ZANCHETTI A.Functional role of renal afferents[J].Physiol Rev,1991,71:659-682.
[16] ATHERTON D S,DEEP N L,MENDELSOHN F O.Micro-anatomy of the renal sympathetic nervous system[J].Clin Anat,2012,25(5):628-633.
[17] TAM G M,YAN B P,SHETTY S V,et al.Transcatheter renal artery sympathetic denervation for resistant hypertension:an old paradigm revisited[J].Int J Cardiol,2013,164(3):277-281.
[18] SMITHWICK R H,THOMPSON J E.Splanchnicectomy for essential hypertension; results in 1,266 cases[J].J Am Med Assoc,1953,152:1501-1504.
[19] MORRISSEY D M,BROOKES V S,COOKE W T.Sympathectomy in the treatment of hypertension; review of 122 cases[J].Lancet,1953,1(6757):403-408.
[20] KRUM H,SCHLAICH M,WHITBOURN R,et al.Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study[J].Lancet,2009,373:1275-1281.
[21] VOSKUIL M,VERLOOP W L,BLANKESTIJN P J,et al.Percutaneous renal denervation for the treatment of resistant essential hypertension; the first Dutch experience[J].Neth Heart J,2011,19:319-323.
[22] KRUM H,SCHLAICH M,WHITBOURN R,et al.Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study[J].Lancet,2009,373:1275-1281.
[23] ESLER M D,KRUM H,SOBOTKA P A,et al.Renal sympathetic denervation in patients with treatment-resistant hypertension(The Symplicity HTN-2 Trial):a randomized controlled trial[J].Lancet,2010,376:1903-1909.
[24] VASE H,MATHIASSEN O N,KALTOFT A.Catheter-based renal denervation for treatment of resistant hypertension[J].Dan Med J,2012,59(6):A4439.
[25] MAHFOUD F,CREMERS B,JANKER J,et al.Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension[J].Hypertension,2012,60:419-424.
[26] RIPPY M K,ZARINS D,BARMAN N C,et al.Catheter-based renal sympathetic denervation:chronic preclinical evidence for renal artery safety[J].Clin Res Cardiol,2011,100:1095-1101.
[27] THOMAS G,SHISHEHBOR M H,BRAVO E L,et al.Renal denervation to treat resistant hypertension:Guarded optimism[J].Cleve Clin J Med,2012,79:501-510.
[28] RIPPY M K,ZARINS D,BARMAN N C,et al.Catheter-based renal sympathetic denervation:chronic preclinical evidence for renal artery safety[J].Clin Res Cardiol,2011,100:1095-1101.
[29] MAHFOUD F,CREMERS B,JANKER J,et al.Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension[J].Hypertension,2012,60(2):419-424.
[30] DORR O,LIEBETRAU C,MOLLMANN H,et al.Renal sympathetic denervation does not aggravate functional or structural renal damage[J].J Am Coll Cardiol,2013,61(4):479-480
[31] HERING D,MAHFOUD F,WALTON A S,et al.Renal denervation in moderate to severe CKD[J].J Am Soc Nephrol,2012,23:12507.
[32] NKESTIJN P J,JOLES J A.Hypertension:Renal denervation [JP3] in chronic kidney disease[J].Nat Rev Nephrol,2012,8:43940.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 412000 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364